Option chain shows key data for AI Unlimited Gr's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for AI Unlimited Gr.

AI Unlimited Gr (OTC:AIUG) Stock, Option Chain

AI Unlimited Group Inc formerly Lever Global Corp is a fintech-driven consumer liabilities and debt management company. Its App allows the subscribers to analyze their existing student loans and recommend programs the US Department of Education offers after the initial assessment and processes enrolments into these programs. The App provides a list of qualified federal programs. The subscribers can digitally enroll in these programs by uploading or self-declaring their W-2, wage, or tax statements through the App.

LEVER GLOBAL CORP by Lever Global Corporation

AI Unlimited Group Inc

During the interim period until the transaction closes, Ansys will continue to offer Ansys PowerArtist as part of its product line, and is committed to providing the same high-quality service its customers have come to expect.

News

Asset Sales

ANSS

Ansys Says Sale Of PowerArtist Is Not Material To Its Financials; Terms Of Agreement Were Not Disclosed

Ansys and Synopsys determined that the sale of PowerArtist was necessary to obtain regulatory approval for Synopsys' proposed acquisition of Ansys.

KEYS

SNPS

Ansys Enters Definitive Agreement For Sale Of Its PowerArtist Business To Keysight Technologies

<ul>
<li>Primary endpoint of overall function (ALSFRS-R) and survival, and key secondary endpoints of muscle strength and respiratory function, were not met at 24 weeks</li>
<li>Overall, DNL343 was found to be safe and well tolerated</li>
<li>Additional analyses, including neurofilament light (NfL) and other fluid biomarkers, prespecified sub-group analyses and analyses from the active treatment extension period are expected later in 2025 &nbsp;</li>
</ul>

Biotech

General

DNLI

Denali Therapeutics Announces Topline Results For Regimen G Evaluating eIF2B Agonist DNL343 In Phase 2/3 HEALEY ALS Platform Trial; Study Did Not Meet Primary Endpoint

NNN REIT, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNN#NYSE">NNN</a>), a real estate investment trust, today announced that Kevin B. Habicht, Executive Vice President, Chief Financial Officer, Assistant Secretary, Treasurer and the Company's principal financial officer, will retire and step down as a member of the Board of Directors effective March 31, 2025.&nbsp; Vincent H. Chao will join NNN as Executive Vice President on January 9, 2025, and assume the positions of Chief Financial Officer, Assistant Secretary and Treasurer and serve as the Company's principal financial officer effective April 1, 2025.
Mr. Habicht has served as Executive Vice President and Chief Financial Officer of the Company since December 1993, and as Treasurer of the Company since January 1998 and as a director of the Company since June 2000. Mr. Habicht served as Secretary of the Company from January 1998 to May 2003.

Management

NNN REIT Announces Kevin B. Habicht, Executive Vice President, CFO, Assistant Secretary, Treasurer And The Co's Principal Financial Officer, Will Retire, Effective March 31, 2025. Vincent H. Chao Will Join As Executive Vice President On January 9, 2025, And Assume The Positions Of CFO, Assistant Secretary And Treasurer And Serve As The Co's Principal Financial Officer Effective April 1, 2025

Jack A. Hockema, Executive Chair of the Board of Directors and Chair of the Executive Committee of the Board, notified the Board of his decision to retire as a director of the Company, effective January 1, 2025.&nbsp;
&nbsp;

KALU

Kaiser Aluminum Names Keith A. Harvey,  Company's President, CEO And A Director, As Chairman Of The Board

Contracts

MPTI

MtronPTI Receives Over $10M Production Contract For A US Defense Program

Krystal Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRYS#NASDAQ">KRYS</a>) has outperformed the market over the past 5 years by 12.62% on an annualized basis producing an average annual return of 25.44%. Currently, Krystal Biotech has a market capitalization of $4.45 billion. 
Buying $1000 In KRYS: If an investor had bought $1000 of KRYS stock 5 years ago, it would be worth $3,017.82 today based on a price of $155.81 for KRYS at the time of writing.
<h3>Krystal Biotech's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736199008_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

KRYS

Here's How Much $1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today

Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>), American Airlines Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) and Southwest Airlines Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) shares traded higher on Monday. Here&#8217;s what <a href="https://www.benzinga.com/general/travel/25/01/42809678/delta-southwest-american-and-others-airlines-halt-over-1300-flights-on-monday-after-severe-winter-storm">you need to know</a>.
What To Know: <a href="https://www.benzinga.com/general/travel/24/12/42705878/airline-stocks-outperform-tech-in-2024-holiday-travel-expected-to-see-records-this-year">Airlines</a> and other travel-related stocks moved higher on Monday after Transportation Security Administration (TSA) traveler screening data showed record travel figures for the end of 2024.
Near the end of last week, TSA <a href="https://x.com/TSA/status/1875202022737412371">posted</a> on X that it screened almost 39 million individuals from Dec. 19 through Jan. 2, marking its &#8220;busiest end of year travel period ever.&#8221; For all of 2024, TSA said officers screened a record 904 million people at airport checkpoints across the nation.
The government agency <a href="https://www.tsa.gov/travel/passenger-volumes/2024">reported</a> that 2,172,907 travelers were screened on New Year&#8217;s Eve, 2,039,342 were screened on Christmas and 1,551,896 were screened on Thanksgiving.
The increase in TSA screenings indicates strong demand for air travel during the holiday season, which may boost ticket sales and revenue for airlines. Additionally, the high number of passengers highlights the resilience of the travel industry, suggesting continued post-pandemic growth.
Investors won&#8217;t have to wait long to get holiday travel data from the airlines. Notably, Delta is expected to release 2024 fourth-quarter and fiscal-year earnings at the end of the week. Analysts expect quarterly earnings per share of $1.76 and revenue of $14.19 billion, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>. Several other airlines are scheduled to report earnings in the coming weeks. 
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42828238/gemini-resolves-cftc-lawsuit-with-5m-settlement-over-bitcoin-futures-misstatements">Gemini Resolves CFTC Lawsuit With $5M Settlement Over Bitcoin Futures Misstatements</a>
DAL, AAL, LUV Price Action: Delta shares shares closed Monday up 1.75% at $60.03, American shares closed the day up 3.24% at $17.52 and Southwest shares closed up 0.62% at $33.82, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image via Shutterstock

Travel

Movers

What's Going On With Delta, American And Southwest Airlines Shares Monday?

APA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APA#NASDAQ">APA</a>) today announced key updates to its executive leadership and corporate officers.
Clay Bretches, executive vice president, Operations, has announced plans to retire July 1, 2025. As part of its commitment to maintaining excellence in operations, the company has launched an internal and external search for a new leader to drive continued innovation and operational efficiency. Bretches will remain with the organization and help ensure a smooth transition to a new leader, anticipated in the first half of 2025.

APA Corporation Announces Clay Bretches, Executive Vice President, Operations, Has Announced Plans To Retire July 1, 2025

New financing arrangement reduces Company's cost of capital by approximately 40%
Further enhances financial flexibility, cash generation and ability to support growth strategy
CHICAGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- FreightCar America, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAIL#NASDAQ">RAIL</a>) ("FreightCar America" or the "Company"), a diversified manufacturer and supplier of railroad freight cars, railcar parts and components, today announced it has completed a new term loan facility. The proceeds from the term loan will be used to redeem all outstanding shares of Series C Preferred Stock, as well as settle all related accrued dividends.
Highlights:
<ul>
<li>The Company closed a $115 million 4-year term loan agreement on December 31st, 2024 (the "Term Loan").</li>
<li>Proceeds from the Term Loan were used to redeem all 85,412 shares of Series C Preferred Stock that were outstanding and all accrued dividends as of December 31st, 2024.</li>
<li>The Term Loan is priced at SOFR + 600, which will reduce the Company's existing cost of capital by approximately 40%, resulting in savings of approximately $9.2 million in the first year, or approximately $0.26 per share on a fully diluted basis.</li>
</ul>

Financing

RAIL

FreightCar America Announces Agreement To Redeem All Outstanding Preferred Shares With New Term Loan; New Financing Arrangement Reduces Company's Cost Of Capital By ~40%

CX-2051 (EpCAM PROBODY ADC) has been prioritized as the Company's lead program with an initial focus in advanced metastatic CRC.
Early-stage research and platform capabilities to be concentrated on existing and potential future partnerships during 2025.
&nbsp;

CTMX

CytomX Therapeutics Expects Revised Focus And Associated Cost And Headcount Reductions  To Extend Cash Runway Into Q2 Of 2026

Macquarie analyst Tim Nollen maintains Comcast (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) with a Neutral and maintains $42 price target.

Price Target

Analyst Ratings

CMCSA

Macquarie Maintains Neutral on Comcast, Maintains $42 Price Target

Omega Healthcare Investors Appoints Matthew Gourmand As President; COO Dan Booth Resigns

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.avanan.click%2Fv2%2F___http%3A%2Fwww.heliostechnologies.com___.YXAzOmtlaWFkdmlzb3JzOmE6bzphNTEwZmNmMjRiNzQwOWQxNjcwNGFjOTcyMjUxOGQ5Njo2OmZiN2Y6YjhmNjVmYzJmYjE0NzI0ZjcxY2VhYzM4MTI0MmFjOTIyZGQ1MjcxN2Q5ZTFlOTA5NGI0YWRjNzhhNWNlYWQzYjpwOlQ6Rg&amp;esheet=54173872&amp;newsitemid=20250106056303&amp;lan=en-US&amp;anchor=Helios+Technologies&amp;index=1&amp;md5=d9b68e235490322f6e275f35549e2206">Helios Technologies</a>, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLIO#NYSE">HLIO</a>) ("Helios" or the "Company"), a global leader in highly engineered motion control and electronic controls technology, today announced that its Board of Directors has promoted Sean P. Bagan to President and Chief Executive Officer, effective immediately. Mr. Bagan has also been nominated to the Company's Board of Directors and will be eligible for election at the June 2025 Annual Meeting. The Board, through an external search firm, conducted a thorough search process consisting of internal and external candidates. Mr. Bagan has been serving as the Interim President, Chief Executive Officer and Chief Financial Officer <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heliostechnologies.com%2Fnews%2Fpress-releases%2Fdetail%2F292%2Fhelios-technologies-announces-leadership-team-update&amp;esheet=54173872&amp;newsitemid=20250106056303&amp;lan=en-US&amp;anchor=since+July+8%2C+2024&amp;index=2&amp;md5=273ae25b7dca71647c7241ef6038fe8c">since July 8, 2024</a>. He will continue as Chief Financial Officer as Helios will now initiate a search to backfill Mr. Bagan's previous role. In addition, Philippe Lemaitre will resume his role as Non-Executive Chairman.

HLIO

Helios Technologies Appoints Sean P. Bagan As President And CEO, Effective Immediately

Macquarie analyst Tim Nollen maintains Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a Neutral and maintains $110 price target.

Macquarie Maintains Neutral on Walt Disney, Maintains $110 Price Target

Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) has outperformed the market over the past 10 years by 7.59% on an annualized basis producing an average annual return of 19.0%. Currently, Fiserv has a market capitalization of $116.99 billion. 
Buying $1000 In FI: If an investor had bought $1000 of FI stock 10 years ago, it would be worth $5,714.33 today based on a price of $205.63 for FI at the time of writing.
<h3>Fiserv's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736198108_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Fiserv 10 Years Ago Would Be Worth Today

<a href="https://about.fb.com/news/2025/01/dana-white-john-elkann-charlie-songhurst-meta-board-of-directors/" title="https://about.fb.com/news/2025/01/dana-white-john-elkann-charlie-songhurst-meta-board-of-directors/">https://about.fb.com/news/2025/01/dana-white-john-elkann-charlie-songhurst-meta-board-of-directors/</a>

Dana White, John Elkann And Charlie Songhurst To Join Meta Board Of Directors

CytomX Therapeutics Plan To Reduce Its Organizational Headcount By Approximately 40%

Citigroup analyst Patrick Donnelly maintains Icon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLR#NASDAQ">ICLR</a>) with a Buy and lowers the price target from $300 to $290.

ICLR

Citigroup Maintains Buy on Icon, Lowers Price Target to $290

WIIM

ULTA

Ulta Beauty shares are trading higher after the company issued Q4 expectations for modest comparable sales growth and an operating margin above the previous estimate.

Comments

AI Unlimited Gr

AI Unlimited Gr (AIUG) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga